Table 3.
1) Replacement therapy | - Fresh-frozen plasma |
2) Anticoagulants | - Unfractionated and low-molecular-weight heparin |
- Danaparoid sodium | |
- Recombinant hirudin | |
- Recombinant tissue factor pathway inhibitor | |
- Recombinant nematode anticoagulant protein c2 | |
3) Restoration of anticoagulant pathways | - Antithrombin |
- Recombinant human activated protein C | |
4) Other agents | - Recombinant activated factor VII |
- Antifibrinolytic agents | |
- Antiselectin antibodies | |
- Recombinant interleukin-10 | |
- Monoclonal antibodies against TNF and CD14 |